BioSciences and a share repurchase, indicating a strong financial position. Despite a 2% year-over-year decrease in third-quarter revenue, Illumina raised its guidance for both operating margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback